Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT00003034
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed malignant pleural or peritoneal mesothelioma
* Measurable or evaluable disease
* CALGB groups 1-4
* No CNS metastases
PATIENT CHARACTERISTICS:
Age:
* 21 and over
Performance status:
* ECOG 0-1
Life expectancy:
* Not specified
Hematopoietic:
* WBC greater than 3,500/mm\^3
* Absolute neutrophil count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
Hepatic:
* SGOT no greater than 2 times upper limit of normal
* Bilirubin no greater than 2 mg/dL
* PT and PTT normal
Renal:
* Creatinine normal
Cardiovascular:
* No symptomatic New York Heart Association class II-IV cardiovascular disease
* No congestive heart failure
* No angina pectoris
* No cardiac arrhythmias
* No uncontrolled hypertension
* No cerebrovascular disease
Metabolic:
* No serum calcium, phosphate, electrolyte, or other metabolic abnormalities, such as metabolic acidosis
Other:
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No serious infection
* No uncontrolled psychosis or neurologic disease (e.g., seizure disorders)
* No uncontrolled diabetes mellitus
* No other primary malignancy within the past 5 years except nonmelanoma skin cancer
* No senility or emotional instability
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No more than one prior systemic chemotherapy regimen
* No prior doxorubicin
* At least 6 weeks since prior chemotherapy
Endocrine therapy:
* Not specified
Radiotherapy:
* Prior radiotherapy for progressive or recurrent disease allowed except myocardium radiotherapy
Surgery:
* Prior surgical resection allowed
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00003034
Study Brief:
Protocol Section:
NCT00003034